Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study by Valeh A Mirzazada, Ramila A Huseynova, Sevil A Mustafayeva, Fidan N Gasimova, Ulviyya Ahmadova, Narmin Ismayilova, Vafa Kerimova, Hagigat Mehdiyeva, Rana Suleymanova, Zahrakhanim Maharramova, Gulnara Iskandarli, Ofeliya Gurbanova, Sariyya Aghayeva, Sabina Malikova, Konul Ismayilova, Khanim Salimkhanova

Get full text